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1119-59 Measurement of Myocardial Infarct Size in Mice Using 
Pinhole Single Photon Emission Computed 
Tomogrsphy 
Max C. Wu, Richard E. Sievers, Dong Wei Gad, Randall J. Lee, Bruce H. Hasegawa, 
Michael W. Dae. University of California San Francisco, San Francisco, Cafifomia. 
Background: The transgenic mouse has become a dominant model to assess myocar- 
dial disease; however, physiologic measurements are often difficult to perform. We 
assessed the feasibility of noninvasively measuring myocardial infarct size in murine 
myocardium. 
Methods: We constructed a single photon emission computed tomography (SPECT) 
system capable of producing clinical quality myocardial perfusion images of mice. The 
system consists of a scintillation camera with a 1 mm pinhote collimator that produces a 
magnified image of the object. Objects are rotated vertically in front of the camera to 
acquire tomographic projection data. We performed phantom studies to assess the sys- 
tem spatial resolution, sensitivity, and uniformity for a variety of magnification factors. 
Control myocardial perfusion studies (n=6) were performed using BALB/c mice (18-23 g). 
Mice were anesthetized, injected with 7-14 mCi of 99mTc-sestamibi, and imaged in a cus- 
tom designed plastic tube. After a 20 minute SPECT acquisition, mice were sacrificed, 
and their heads were removed, frozen, and sectioned for autoradiography of 99rnTc. The 
left anterior descending coronary artery in the study group (n=11) was permanently 
ligated to create acute myocardial infarction. The chest was closed, and the mice were 
imaged according to the control protocol, followed by autoradiography. 
Reaults: Five representative short-axis slices were chosen from each SPECT image, 
and regional perfusion was quantified using circumferential profile analysis, where the 
maximum intensity along rays from the center of the slice was plotted as a function of 
angle. The threshold, derived from the control studies, for determining whether an angu- 
lar sample was part of the infarct was set at 50% of the maximum intensity. For each 
mouse, the % infarcted myocardium was determined from the SPECT image and corre- 
lated to an area fraction measurement derived from autoradiography. The correlation 
coefficient r=0.80 was significant o a level of p<0.005. 
Conclusion: Noninvasive quantitative assessment of myocardial perfusion defect size is 
feasible in murine myocardium. This methodology may allow serial assessment of novel 
interventions to reduce infarct size. 
1119-60 Evidence for Increased Angiotenain II Type I Receptor 
Immunoreectivity in Peri-lnfarct Myocardium of Human 
Explanted Hearts 
Vasken Dilsizian. Maria Loredo, Victor J. Fsrrans, Elaine M. Jagoda, William C. 
Eckelman, Jamshid Shirani, University of Maryland Medics~ Center, Baltimore, Maryland, 
National Institutes of Health, Bethesda, Maryland. 
Background: Upregulation of angiotansin-conveding enzyme (ACE) has been implicated 
in left ventricular (LV) remodeling and fibrosis in heart failure. We recently synthesized a 
new radiotracar, [18F]fluorobenzoyl-lisinopril, which showed specific binding to ACE in 
human heads with ischemic cardiemyopathy (I-CMP). [18F]fluorobenzoyl-lisinopril bind- 
ing was nonuniform in infarct and noninfarct segments, with increased binding in areas 
adjacent o replacement fibrosis. If upregulation of ACE is reversible, e.g,, by ACE inhibi- 
tors, noninvasive imaging with PET may allow monitoring the effects of medical and/or 
interventional therapy on disease progression. Methods: We applied the peroxidase 
method to examin e histochemically the distribution of angiotensin II receptors (AnglI-R) 
in normal, infarct and peri-infarct myocardium, and in the heads of patients (n = 3) with I- 
CMP. A polyclonal antibody against the human Angll AT1 receptor (Santa Cruz Biotech- 
nology, Inc.) was used (1:100 dilution) in conjunction with the Vectastain Elite ABC kit. 
For antigen retrieval, 5 to 10 mm-thick sections were immersed in a 0.4% pepsin solution 
in 0.1 N HCI for 10 min at 37oC, followed by blocking with 2% bovine serum albumin and 
10% normal goat serum. The sections were then incubated overnight with Anglt anti- 
body. Bronchial and vascular smooth muscle cells from lung tissue of patients without 
pulmonary disease served as positive controls. Results: In noninfarct myocardium, Angll- 
R immunoreactivity was confined to smooth muscle and eodothalium. Myocytes were 
unreactive. In contrast, in peri-infarct myocardium, there was increased immunoreactivity 
for AngH-R, which was localized in the myooytes. Although some AnglI-R immunoreactiv- 
ity was also seen in infarct myocardium, it was localized predominantly in fibroblasts or 
within islands of surviving myocytes. Conclusion: These data confirm our previous quan- 
titative autoradiographic observations concerning [18F]fiuorobenzoyl-lisinopril binding in 
normal, infamt and peri-infarct myocardium. The immunoreactivity for AnglI-R in the peri- 
infarct and infarct myocardium suggests a role of Angll in LV remodeling and fibrosis in 
chronic I-CMP. 
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1119-61 Reduced Metabolic Reserve in Both Right and Left 
Ventricles in Patients With Heart Failure 
Heikki Ukkonen, Rob Seanlaods, Juhani Knuuti, Liisa-Maria Voipio-Pulkki, Turku PET 
Centre, Turku, Finland, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. 
Background: In patients with congestive heart failure (CHF), right ventricular (RV) func- 
tion contributes to exercise tolerance and also carries prognostic value. Oxidative metab- 
olism (OM) reserve may be impaired in these patients. However, the OM in the RV is 
poorly characterized in CHF patients. 11C-acetate PET imaging allows assessment of 
OM in both LV and RV simultaneously. 
Subjects and methods: LV and RV oxidative metabolism was assessed in 5 male 
patients with CAD and LV dysfunction (LVEF 30~3 %, NYHA Class 2 to 3) and in 5 
healthy male volunteers using the clearance rate constant (kmono) from 11C-acetate PET 
imaging at rest and during dobutamine infusion (5-7.5 microg/kg/min). 
Results: In HV dobutamine increased OM by 100% in RV (krnono: 0.04210.004 to 
0,084-+0.008, p=0.002) and by 58% in LV (0.064:L-0.008 to 0.100~0.010, p=0.002), RV 
OM increased relatively more as RV/LV krnon o ratio increased by 27% (67_+3 to 84±4 %, 
p=O.004). In CHF patients the responses were blunted: RV kmono 0.054-+0.017 vs. 
0.067±0.010, LV kmono 0.8581-0.007 vs. 8,067_+0.012 and RV/LV krnon o ratio 95±33 % vs. 
102+18%, p=NS. Baseline RV/LV kmono ratio was higher in CHF patients (p=8,059) 
Conclusions: In healthy hearts dobutamine increases RV/LV ratio by 27 %, which 
emphasizes the role of the RV in normal response to stress. In patients with CAD and LV 
dysfunction the metabolic response to dobutamine is impaired and the RV/LV kmono ratio 
is elevated suggesting an imbalance in RV and LV metabolism,11C-ecetate PET allows 
the assessment of RV oxidative metabolism relative to the LV which may be an important 
alteration in CHF. 
1119-62 Comparison of the Prognostic Value of Cardiac 1-123 
Metaiodobenzylguanidine Imaging and Heart Rate 
Variabil ity in Patients With Mild to Moderate Chronic 
Heart Failure 
Takahisa Yamada, Masatake Fukunami, Tsuyoshi Shimonagata, Kazuaki Kumagai, Akio 
Hirata, Mitsutoshi Asai, Nobuhiko Makino, Hidataka Kioka, Noritake Hoki, Osaka 
Prefectural General Hospital, Osaka, Japan. 
Background: Cardiac 1-123 metaiodobenzylguanidine (MIBG) images, which would 
reflect the cardiac adrenergic nerve activity, provide prognostic information in patients 
with chronic heart failure (CHF). Reduced heart rate variability (HRV), indicating 
derangement in cardiac autonomic ontrol, was also reported to be associated with poor 
prognosis in CHF patients. No information is available on the comparison of the prognos- 
tic value of MIBG and HRV in CHF patients. 
Methods: At the entry, MIBG imaging and 24 hour Holter monitorings were performed in 
65 stable outpatients with CHF (NYHA: 2.0-+0.6, ischemic origin: 83%) whose radionu- 
clide left ventricular ejection fraction was less than 40% (28+8%). The cardiac MIBG 
heart to madiastinum ratio (H/M) and washout rate (WR) were calculated from the chest 
anterior view images obtained at 20 and 200 min after isotope injection. The time and fre- 
quency domain parameters of HRV were calculated from 24 hour Halter recordings. 
Results: During the follow-up period of 34±19 months, 13 of 65 patients had cardiac 
events (death [n=4], hospitalization for worsening CHF [n=9]). At univariata Cox analysis, 
out of the variables including clinical, echocardiogrphic, hemodynamic, biochemical, 
MIBG and HRV parameters, WR (p<8.0001), H/M(delayed) (p=0.01), normalized very 
low frequency (n-VLF: 0.003-0.04 Hz) power (p=0.04), left atrial dimension (p=0.006) and 
plasma noradrenaline level (p=0.01) showed a significant association with the cardiac 
events. At multivariate Cox analysis, WR was an independent predictor of the cardiac 
events (p=0.029, hazard ratio 1.072 [95%CI 1.007-1.14]). Risk ratio of cardiac events in 
patients with abnormal WR (>27%: mean+2SD obtained from 20 normal controls) was 
6.0 (95%CI 1.5 to 25.1), which was greater than risk ratio (3.9 [95%C1 1.5 to 10.3]) in 
patients with abnormal n-VLF power (<22: mean-2SD obtained from normal controls). 
Kaplan-Meier analysis revealed that the cardiac events were significantly more often 
observed in patients with than without abnormal WR (36% vs 6%, p=0.001). 
Conclusion: MIBG washout rate has higher prognostic value than HRV parameters in 
patients with mild to moderate CHI~ 
1119-63 B1-Adrenergic Receptor Gene Polymorphism 
Modulates Cardiac Sympathetic Innervation in Patients 
With Dilated Cardiomyopathy 
Chikao Iwai. Hozuka Akita, Nobuyuki Shiga, Eiji Takai, Yoshitomo Miyamoto, Masakatsu 
Shimizu, Sei Fujiwara, Hiroya Kawai, Shin-ichioro Yamada, Akira Takarada, Teishi 
Kajiya, Mitsuhiro Yokoyama, Division of Cardiovascular and Respiratory Medicine, Kobe 
University Graduate School of Medicine, Kobe, Japan, Department of Cardiology, Himaji 
Cardiovascular Center, Himeji, Japan. 
Background: Iodine 123-metaiodebenzylguanidine (MIBG) is a tracer for imaging of car- 
diac sympathetic (CS) innervafion. Many studies reported that MIBG scintigrphy was a 
useful noninvasive method for the assessment of prognosis of Dilated Cardiomyopathy 
(DCM). In addition, CS function estimated by MIBG imaging has shown to be the predic- 
tor of favorable response to ~,-blockers (including ~1 selective) in DCM, implying the 
interaction of ~l-adrenergic receptor ([]IAR) function with CS innervation in heart failure. 
Recently, a common functional ~IAR gene polymorphism (Arg389Gly) has been identi- 
fied. In vitro functional assays revealed that adenylyl cyclase activities for the Arg389 
were 3 times higher than those for the Gly389 with agonist stimulation. Hence, we spec- 
ulate that Arg389 may induce more prominent CS dysfunction compared with Gly389 in 
DCM. 
Methods: in 54 Japanese patients with DCM (40 men, 58,9±1.5 years, left ventricular 
ejection fraction (EF); 31.4+1.5%), we studied MIBG imaging and gene analysis for the 
genotyping as described previously, The heart to mediastinum MIBG uptake ratio (H/M) 
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was evaluated on initial and delayed images in 4 hours tracer injection. The washout rate 
of myocardial MIBG (WR) was also obtained from these data using relative decrease in 
cardiac activity measured at 15 minutes and 4 hours. 
Results: Patients were divided into group A (n=36) genotyped Arg389, and group B 
(n=18) genotyped Arg389Gly or Gly389. No significant differences were found with 
regard to medication use including ~-blockers between group A and group B (18% vs 
6%). Initial and delayed H/M in group A were not statistically different from those in group 
B (initial H/M; 2.04£-0.06 vs 2.13 + 0.06, delayed H/M; 1.82+0.06 vs 2.01±0.08). WR was 
significantly higher in group A than in group B (48.4+P.2% vs 38.3_+3.6%, P=0.02). Left 
ventricular function estimated by EF was not different between 2 groups (31.6+1.9% vs 
31.1+2.4%). 
Conclusion: Our findings suggest that Arg389Gly polymorphism in ~IAR gene is asso- 
ciated with attenuated CS nervous system activity, which can be the predictor of favor- 
able p-blooker esponse, in patients with DCM. The Arg389 DCM patients may be good 
candidates for J3-blocker therapy. 
1119-64 Functional Fate After Revascularizatlon of Myocardium 
With Intact Perfusion but Without Contractile Reserve 
Jeroen J. Bax. A. Schinkel, E. Boersma, A. Elbendy, D. Poldermans, Leiden University 
Medical center, Leiden, The Netherlands, Thorax Center Rotterdam, The Netherlands. 
It is currently unclear whether myocardium with intact perfusion but without contractile 
reserve will improve in function post-revasculadzation. Therefore, we evaluated patients 
with chronic ischemic left ventricular (LV) dysfunction before revascularizatioo with myo- 
cardial perfusion imaging and dobutamine stress echooardiography. Thus, 108 patients 
with ischemic cardiomyopathy (LVEF 34±10%), scheduled for CABG, underwent both 
resting tetrofosmin SPECT (to evaluate resting peffusion) and dobutamine echocardio- 
graphy (to evaluate contractile reserve). Resting LV function was evaluated before revas- 
cularizabon, and late (9-12 months) post-revascularization by 2D echocardiography (16- 
segment model). Before revasculadzation, 1336 segments were dysfunctional. Improve- 
ment in function was observed in 357 (27%) dysfunctional segments, whereas 979 dys- 
functional segments did not improve. The majority of the segments with improvement 
post-ravascularization exhibited both preserved beffusion and contractile reserve (66%). 
The majority of the segments without improvement of function post-rsvasculadzation did 
not have preserved perfusion or contractile reserve (58%). Of interest, 22% of the seg- 
ments with improvement and 25% of the segments without improvement showed pre- 
sewed perfusion but did not have contractile reserve. Thus, dysfunctional myocardium 
with preserved contractile reserve and intact perfusion has a high likelihood of functional 
recovery post-revasculadzation; segments without contractile reserve/perfusion have a 
low likelihood of recovery, Segments with preserved berfusion but without contractile 
reserve have an intermediate likelihood of recovery, 
1119-65 Comparison of Fluorodeoxyglucose Positron 
Emmission Tomograpy and Nonfluoroscopic 
Electroanatomical Mapping in Myocardial Viability 
Assessment 
Mariann Gvonevosi, Santa Graf, Dietmar Glogar, Aliashgar Khorsand, Christian Pirich, 
Heinz Soohor, Gerold Porenta, Division of Cardiology, University of Vienna Medical 
School, Vienna, Austria, Rudolfinerhaus, Vienna, Austria. 
Background. Nonfluoroscopic electroanatomicel mapping is a novel technique that 
enables to acquire an on-Une information on electrical and mechanical signal of myocar- 
dial tissue in the catheterization laboratory. The aim of the present study was to compare 
the diagnostic value of NOGA electroanatomical mapping with fluorodeoxyglucose 
positron emmission tomograpy (FDG-PET) and resting and late resting 201-Thallium 
myocardial perfusion scintigraphy in the myocardial viability assessment. 
Methods. Twenty patients with isohemic coronary artery disease and stable angina pec- 
toris underwent electroanatomic mapping, FDG-PET and 201-Thallium resting-lata rest- 
ing scintigraphy. After exclusion of 5 patients with perfusion metabolism mismatch, data 
on 15 patients (80% male, 61±11y) were analysed. The quantitative FDG-PET and Thal- 
lium uptake data were calculated by polar map analysis by division into 12 comparable 
myocardial segments, as represented in the electroanatomic mapping image. Results. 
Significant logarithmic orrelation was found between NOGA unipolar voltage and FDG 
uptake values (r=0.685, p<0.001) as well as late resting Thallium-201 uptake (r=0.797, 
p,¢0.001). Nonviable myocardial segments (late resting Thallium-201 uptake<50%) 
exhibited 4.7±1.9 mV endocardial potentials and 39.9±10.3% FGD uptake, while 
ischemic but still viable (late resting Thallium-201 uptake between 51-75%) and normal 
myocardium (late resting Thallium-201 uptake >75%) displayed 8.6±3.7 mV and 
13.5±4.8 mV endocardial voltage potentials and 65±13.5 and 76.4±9.9% FDG uptake. A 
good concordance between unipolar voltage and FDG-PET values was observed in the 
nonviable myocardial areas. However, in myocardial territories of normal and mild 
reduced viability, unipolar voltage values exhibited greater scattering, leading to an 
underestimation of the myocardial viability in these segments. Conclusion. Despite a glo- 
bal good correlation between endocardial unipolar voltage values and FDG uptake, it 
seems, that NOGA electroanatomical mapping overestimates the severity of resting 
myocardial ischemia in comparison with FDG PET. 
1119-66 Left Ventricular Functional Impairment in Chronic Heart 
Failure Patients Is Independent of Extent of Perfusion 
Defects end Viable Myocardium 
Mada Anoela Oxilia-Estioarribia. James Sayre, Gregg Fonarow, Heinrich R. Schelbert, 
UCLA School of Medicine, LA, California. 
Purpose; We tested the hypothesis that the left ventdcular ejection fraction (LVEF) in 
chronic heart failure (CHF) patients declines as a function of the perfusion defect size. if 
true, then the fraction of hypoperfused but viable myocardium could predict a post-revas- 
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cularization increase in LVEE 
Methods: In 104 CHF patients, an LVEF of 24±7.3% (range 10 to 40%)and referred for 
cardiac transplant evaluation, the sizes of mismatch (MM, viable) and match (M,scar) 
myocardium on rest perfusion (13N-ammonia) and 18F-deoxyglucose PET images were 
determined by quantitative polar map analysis (Munich Heart Analysis) in % LV corre- 
lated with the LVEF determined clinically by angiography, radionuclide imaging or 2D- 
echocardiography. 
Results: Perfusion defect sizes (sum of MM and M), ranged from10 to 40 %(avg.24±7.3), 
and did not correlate with LVEF (R2=0.01). There was also no correlation for LVEFs by 
angiography only, excluding a method related variability in LVEFs. Similarily, no correla- 
tion was found for LVEFs with primarily MM (*40% mismatch and -20% of match, n:13, 
20.7±6.7, R2=0.08) or primarily M (*40% match and -20% of mismatch, n:10, LVEF 
23.2±8.1, R2=0.07) defects. Neither stress induced ischemia (n= 25, LVEF 24±7.0, 
R2=0.01)nor mitral regurgitation (n=4, LVEF 26±9.4, R2=0.01), diabetes (n= 28, LVEF 
26±6.1, R2=0.02) and arterial hypertension (n=32, LVEF 23±7.2, R2=0.0t) influenced 
the lack of correlation between LVEF and perfusion defect size. 
Conclusions: In this highly selected CHF population, the impairment of LVEF was inde- 
pendent of the extent of perfusion defects or hypopoffused but viable myocardium, stress 
induced ischemia or diabetes or aderial hypertension, and most likely resulted from LV 
remodeling. This suggests that the extent of hypoperfused but viable mismatch myooar- 
dium is limited in predicting the degree of post-revascularization a LVEF improvement. 
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1139-53 Insulin Improves Myocardial Mlcrocirculation 
Reperfusion After Acute Ischemia With Hyperglycemia 
Lane Jiaqg, Xuedong Shen, John Lof, Thomas R. Porter, Baystate Medical Center, 
Springfield, Massachusetts, The Cardiac Center of Creighton Universi~ University of 
Nebraska Medical Center, Omaha, Nebraska. 
We have demonstrated hyperglycemia (HG) worsens myocardial microoirculatory raper- 
fusion (RP) after acute ischemia with power pulse inversion imaging (PPI) and Neutron 
Activated Microspheres (MIC). To test the hypothesis that insulin can improve myocardial 
RP, we studied myocardial contrast enhancement during a continuous intravenous infu- 
sion of PESDA microbubNes in 6 dogs for 3 sequential stages: 1) during coronary liga- 
tion, 2) following reperfusion in the presence of HG (plasma concentration of 321± 89rag/ 
all), 3) following insulin intravenous injection with normal plasma concentration. Left ven- 
tricle was imaged on short-axis at mid-papillary muscle level. Ischemic and non-ischemic 
(IR, NIR) regional myocardial blood flow (MBF) was estimated by the product of the rate 
of replenishment and the plateau of myocardial acoustic density at the regions. MIC was 
used for validation. Results: 1) PPI-dedved MBF correlated well with MIC-MBF (r=0.91, 
p<0.0001). 2) During stage 1, MBF was 1.98±1.61 in IR, 7.81±5.46 in NIR. 3) During 
stage 2, MBF only mildly increased in IR (3.79±3.33, p=0.11), but decreased in NIR 
(5.51±6.48, p=0.01). 4) During stage 3, MBF significantly increased both in IR 
24.24±11.96, p=0.006) and in NIR (20.0±7.64, p=0.0002, Fig). 
Conclusion; Insulin improves myocardial blood flow following reperfusion when hyperg- 
lycemia is present. It indicates the importance of intensive insulin therapy for diabetic 
patients during acute ischemia and repeffusion. 
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1139-54 Color-Coded Curved Anatomical M-Mode Analysis of 
Contrast Echocardiography: A Novel Technique for the 
Diagnosis of Coronary Artery Stenosis 
Akiko Iwata. Jyuri Okazaki, Kentaro Ohtani, Hideo Hirayama, Yasushi Kashiwagi, 
Sachiko Yagura, Tsutomu Toshida, Toshihiko Asanuma, Fuminobu Ishikura, Shintaro 
Beppu, Osaka University, Suita, Japan. 
Background: Replenishment curve of intensity after bubble destruction in real-time con- 
trast echocardiography should be useful for diagnosing coronary stenosis. However, it is 
hard and time-consuming to calculate the replenishment curve in every region of the ven- 
tricular wall. Newly developed curved anatomical M-mode (CAMM) provides the tempo- 
ral change of intensity along an arbitrary setting line. 
Purpose: The purpose is to elucidate efficacy of color-coded CAMM for diagnosing an 
area at risk by adenosine triphosphate (ATP) administration. 
